[HTML][HTML] Glutamate-induced excitotoxicity in Parkinson's disease: The role of glial cells
Glutamate is the major excitatory neurotransmitter in the central nervous system. Glutamate
transmission efficiency depends on the correct functionality and expression of a plethora of …
transmission efficiency depends on the correct functionality and expression of a plethora of …
Neuronal cell death
Neuronal cell death occurs extensively during development and pathology, where it is
especially important because of the limited capacity of adult neurons to proliferate or be …
especially important because of the limited capacity of adult neurons to proliferate or be …
Small soluble α-synuclein aggregates are the toxic species in Parkinson's disease
Soluble α-synuclein aggregates varying in size, structure, and morphology have been
closely linked to neuronal death in Parkinson's disease. However, the heterogeneity of …
closely linked to neuronal death in Parkinson's disease. However, the heterogeneity of …
Modeling Parkinson's disease with the alpha-synuclein protein
M Gómez-Benito, N Granado, P García-Sanz… - Frontiers in …, 2020 - frontiersin.org
Alpha-synuclein (α-Syn) is a key protein involved in Parkinson's disease (PD) pathology. PD
is characterized by the loss of dopaminergic neuronal cells in the substantia nigra pars …
is characterized by the loss of dopaminergic neuronal cells in the substantia nigra pars …
Alpha-synuclein research: defining strategic moves in the battle against Parkinson's disease
With the advent of the genetic era in Parkinson's disease (PD) research in 1997, α-synuclein
was identified as an important player in a complex neurodegenerative disease that affects> …
was identified as an important player in a complex neurodegenerative disease that affects> …
The role of α-synuclein oligomers in Parkinson's disease
X Du, X **e, R Liu - International journal of molecular sciences, 2020 - mdpi.com
α-synuclein (α-syn) is a protein associated with the pathogenesis of Parkinson's disease
(PD), the second most common neurodegeneration disease with no effective treatment …
(PD), the second most common neurodegeneration disease with no effective treatment …
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
This article reviews and summarizes 200 years of Parkinson's disease. It comprises a
relevant history of Dr. James Parkinson's himself and what he described accurately and …
relevant history of Dr. James Parkinson's himself and what he described accurately and …
Prions, prionoids and protein misfolding disorders
Prion diseases are progressive, incurable and fatal neurodegenerative conditions. The term
'prion'was first nominated to express the revolutionary concept that a protein could be …
'prion'was first nominated to express the revolutionary concept that a protein could be …
Alpha-synuclein oligomers—neurotoxic molecules in Parkinson's disease and other Lewy body disorders
M Ingelsson - Frontiers in neuroscience, 2016 - frontiersin.org
Adverse intra-and extracellular effects of toxic α-synuclein are believed to be central to the
pathogenesis in Parkinson's disease and other disorders with Lewy body pathology in the …
pathogenesis in Parkinson's disease and other disorders with Lewy body pathology in the …
α-synuclein interacts with PrPC to induce cognitive impairment through mGluR5 and NMDAR2B
DG Ferreira, M Temido-Ferreira… - Nature …, 2017 - nature.com
Synucleinopathies, such as Parkinson's disease and dementia with Lewy bodies, are
neurodegenerative disorders that are characterized by the accumulation of α-synuclein …
neurodegenerative disorders that are characterized by the accumulation of α-synuclein …